Corbus pharmaceuticals holdings, inc. (CRBP)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13
Revenue from awards

36,143

4,822

-

-

-

-

-

Revenue from awards

-

-

2,440

1,911

648

-

-

Operating expenses:
Research and development

89,604

48,613

26,038

15,436

5,888

1,255

210

General and administrative

23,643

12,956

8,964

6,459

3,613

1,391

346

Total operating expenses

113,248

61,569

35,003

21,896

9,502

2,647

557

Operating loss

-77,104

-56,747

-32,562

-19,985

-8,853

-2,647

-557

Other income (expense):
Other income

4,581

-

-

-

-

-

-

Interest income, net

-

-

183

0

0

-

-

Interest expense

-

-

-

-

-

24

45

Interest income, net

1,227

982

-

-

-

2

0

Forgiveness of interest on note payable

-

-

-

-

-

7

-

Gain on the settlement of debt

-

-

-

-

-

145

-

Change in fair value of warrant liability

-

-

-

-

-

28

-1

Foreign currency exchange gain (loss), net

-158

92

-41

-14

1

4

-2

Other income, net

5,650

1,075

141

-13

2

106

-45

Net loss

-71,453

-55,672

-32,421

-19,998

-8,850

-2,540

-602

Net loss per share, basic and diluted

-1.12

-0.98

-0.65

-0.49

-0.28

-0.13

-0.09

Weighted average number of common shares outstanding, basic and diluted

63,899

56,999

50,176

41,137

31,350

20,159

6,964